Simplex Trading’s MaxCyte MXCT Stock Holding History

Simplex Trading’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23K	Hold	1,000	–	–	﹤0.01%	8787
2026 Q1	$702	Buy	+1,000	New	+$934	﹤0.01%	8676
2025 Q1	–	Sell	-500	Closed	-$2K	–	9243
2024 Q4	$2K	Hold	500	–	–	﹤0.01%	8042
2024 Q3	$1K	Sell	500 -400	-44%	-$1.69K	﹤0.01%	8220
2024 Q2	$3K	Buy	900 +500	+125%	+$2.15K	﹤0.01%	8131
2024 Q1	$1K	Sell	400 -1,500	-79%	-$7.04K	﹤0.01%	8602
2023 Q4	$8K	Buy	1,900 +1,100	+138%	+$4.28K	﹤0.01%	7594
2023 Q3	$2K	Sell	800 -300	-27%	-$1.21K	﹤0.01%	8129
2023 Q2	$5K	Buy	1,100 +200	+22%	+$919	﹤0.01%	7935
2023 Q1	$4K	Sell	900 -2,300	-72%	-$11.3K	﹤0.01%	8197
2022 Q4	$17K	Buy	+3,200	New	+$19.6K	﹤0.01%	7037

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Simplex Trading's MXCT Position: Q2 2026 in Review

Simplex Trading reduced its MaxCyte (MXCT) stake by 62% in Q2 2026, selling an estimated $788 and leaving 476 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #8928.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 10 quarters since. The position peaked at $13K in Q3 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Simplex Trading held 476 shares of MaxCyte worth $585 as of Q2 2026.
Simplex Trading sold 791 MaxCyte shares in Q2 2026, an estimated $788.
MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8928 holding.
Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 10 quarters since.
Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.